Pancreatic Cancer Risk Management
Stay up to date on research and information
Sign Up for FORCE NewslettersPancreatic Cancer Risk Management
Every person is at risk for pancreatic cancer and the risk increases with age. A person in the general population has about a 1 percent lifetime risk of developing pancreatic cancer. This means that 1 out of every 100 people will get pancreatic cancer in their lifetime.
An in one of the genes listed below increases the risk for pancreatic cancer.
Genetic counseling and testing can help you learn if you have an in one of these genes. There are different expert guidelines for pancreatic cancer screening, which are based on your level of risk. Read below for more information about different screening options. Speak with your healthcare provider to decide on a risk-management plan and schedule that is right for you.
In the News
Study : Benefit of pancreatic cancer screening
Among people with an inherited mutation in a BRCA1 or BRCA2 gene, screening for pancreatic cancer found most cancers at an earlier stage when they could be treated by surgery. Posted 1/17/24) Este artículo está...
Risk-Management Options
Types of Pancreatic Cancer Screening
Screening for pancreatic cancer uses tests to try to catch cancer in its early stages. Learn more about the types of screening and their benefits and limitations.
Pancreatic Cancer Screening Guidelines
There are two professional groups with guidelines for pancreatic cancer screening for high-risk people that differ in their recommendations. Read more about these guidelines here.
Participate in Pancreatic Cancer Prevention Research
Below are some of our featured research studies looking at new ways to screen for pancreatic cancer. To search for additional studies, visit our Search and Enroll Tool.
Pancreatic Cancer Early Detection for People at High Risk
Clinicaltrials.gov identifier:
NCT04970056
Testing a Vaccine for Cancer Prevention in People with a BRCA1 or BRCA2 Mutation
Clinicaltrials.gov identifier:
NCT04367675
Clinicaltrials.gov identifier:
NCT05677048
Screening for Pancreatic Cancer in Patients with an Inherited BRCA1, BRCA2, PALB2 or ATM Mutation
Clinicaltrials.gov identifier:
NCT02478892